The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $180.71 million. The enterprise value is $176.16 million.
| Market Cap | 180.71M |
| Enterprise Value | 176.16M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 14.78 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Shares Outstanding | 14.78M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 77.44% |
| Float | 10.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 296.32 |
| PS Ratio | 1.52 |
| Forward PS | 1.58 |
| PB Ratio | 7.22 |
| P/FCF Ratio | 18.46 |
| PEG Ratio | -0.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.24, with an EV/FCF ratio of 18.20.
| EV / Earnings | n/a |
| EV / Sales | 1.50 |
| EV / EBITDA | 17.24 |
| EV / EBIT | 107.50 |
| EV / FCF | 18.20 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.32 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 1.73 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.80%.
| Return on Equity (ROE) | -29.80% |
| Return on Assets (ROA) | -10.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $265,082 |
| Profits Per Employee | -$21,964 |
| Employee Count | 444 |
| Asset Turnover | 1.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $11.39 million in taxes.
| Income Tax | 11.39M |
| Effective Tax Rate | 695.10% |
Stock Price Statistics
The stock price has decreased by -20.21% in the last 52 weeks. The beta is 1.58, so The Joint's price volatility has been higher than the market average.
| Beta (1Y) | 1.58 |
| 52-Week Price Change | -20.21% |
| 50-Day Moving Average | 11.65 |
| 200-Day Moving Average | 10.23 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (30 Days) | 91,625 |
Short Selling Information
The latest short interest is 798,477, so 5.40% of the outstanding shares have been sold short.
| Short Interest | 798,477 |
| Short Previous Month | 781,635 |
| Short % of Shares Out | 5.40% |
| Short % of Float | 7.55% |
| Short Ratio (days to cover) | 11.54 |
Income Statement
In the last 12 months, The Joint had revenue of $117.70 million and -$9.75 million in losses. Loss per share was -$0.65.
| Revenue | 117.70M |
| Gross Profit | 107.15M |
| Operating Income | -2.07M |
| Pretax Income | 1.64M |
| Net Income | -9.75M |
| EBITDA | 10.22M |
| EBIT | 1.64M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $19.21 million in cash and $16.73 million in debt, giving a net cash position of $2.48 million or $0.17 per share.
| Cash & Cash Equivalents | 19.21M |
| Total Debt | 16.73M |
| Net Cash | 2.48M |
| Net Cash Per Share | $0.17 |
| Equity / Book Value | 24.75M |
| Book Value Per Share | 1.67 |
| Working Capital | 10.76M |
Cash Flow
In the last 12 months, operating cash flow was $14.68 million and capital expenditures -$5.00 million, giving a free cash flow of $9.68 million.
| Operating Cash Flow | 14.68M |
| Capital Expenditures | -5.00M |
| Free Cash Flow | 9.68M |
| FCF Per Share | $0.66 |
Margins
Gross margin is 91.04%, with operating and profit margins of -1.76% and -8.29%.
| Gross Margin | 91.04% |
| Operating Margin | -1.76% |
| Pretax Margin | 1.39% |
| Profit Margin | -8.29% |
| EBITDA Margin | 8.68% |
| EBIT Margin | 1.39% |
| FCF Margin | 8.22% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | -5.46% |
| FCF Yield | 5.42% |
Analyst Forecast
The average price target for The Joint is $13.00, which is 6.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.00 |
| Price Target Difference | 6.30% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.93 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 6 |